Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck

J Clin Oncol. 2005 Aug 20;23(24):5440-2. doi: 10.1200/JCO.2005.02.002. Epub 2005 Jul 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cetuximab
  • Cisplatin / therapeutic use*
  • Clinical Trials as Topic
  • Disease Progression
  • ErbB Receptors / metabolism
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / metabolism
  • Head and Neck Neoplasms / pathology
  • Humans
  • Survival Analysis

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • ErbB Receptors
  • Cetuximab
  • Cisplatin